Bonner General Hospital Home Health Location: 520 N 3rd Ave, Sandpoint, Idaho 83864 Ratings:NA Phone: (208) 265-1007 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Eden Home Health Location: 530 Pine Street, Sandpoint, Idaho 83864 Ratings: Phone: (208) 255-1640 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Welcome Home Healthcare Services Location: 120 E Lake Street, Suite 319, Sandpoint, Idaho 83864 Ratings: Phone: (208) 263-7007 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Medical Social Services, Home Health Aide |
News Archive
Researchers at University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences have found that the breast cancer drug tamoxifen gives white blood cells a boost, better enabling them to respond to, ensnare and kill bacteria in laboratory experiments. Tamoxifen treatment in mice also enhances clearance of the antibiotic-resistant bacterial pathogen MRSA and reduces mortality.
A newly identified genetic disorder associated with degeneration of the central and peripheral nervous systems in humans, along with the genetic cause, is reported in the April 24, 2014 issue of Cell.
Kaiser Health News reports that "employers struggling with the steady rise of health insurance costs - which in 2009 increased 5 percent to an average of $13,375 for family coverage - are passing on more of the expense to their workers through higher deductibles and co-payments, according to survey released today." The survey was by the Kaiser Family Foundation and the Health Research & Educational Trust (Galewitz and Villegas, 9/15).
A new editorial published by an International Osteoporosis Foundation Working Group urges physicians to individualize treatment decisions based on their patients' fracture risk, rather than automatically interrupting or stopping bisphosphonate therapy after five or three years.
Rodman & Renshaw Capital Group, Inc., today announced that its client Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a focus in oncology, has received commitments from institutional investors to purchase $50 million of securities in a registered direct offering.
› Verified 8 days ago